Volume 23, Number 11—November 2017
Research
Symptom- and Laboratory-Based Ebola Risk Scores to Differentiate Likely Ebola Infections
Table 1
Characteristic | EVD negative, n = 172 | EVD positive, n = 252 |
---|---|---|
Sex, no. (%) | ||
F | 69 (40.1) | 144 (57.1) |
M |
103 (59.9) |
108 (42.9) |
Median age, y (IQR) |
27 (20–40) |
25 (14–35) |
Mode of arrival to facility, no. (%) | ||
Ambulance (referral) | 95 (55.2) | 242 (96.0) |
Walk-in |
77 (44.8) |
10 (4.0) |
Median days between onset of symptoms and admission (IQR) | 3 (2–6) | 3 (2–5) |
Median length of stay at ETC, d (IQR) | 1 (1–2) | 6 (3–11) |
Deaths, no. (case fatality ratio, %) | 12 (7.0) | 107 (42.5) |
*ETC, Ebola treatment center; EVD, Ebola virus disease; IQR, interquartile range.
Page created: October 16, 2017
Page updated: October 16, 2017
Page reviewed: October 16, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.